시장보고서
상품코드
1422073

정형외과용 기기 시장 : 제품별, 용도별, 부위별, 최종사용자별, 지역별, 기회 및 예측(2017-2031년)

Orthopedic Devices Market Assessment, By Product, By Application, By Site, By End-users, By Region, Opportunities and Forecast, 2017-2031F

발행일: | 리서치사: Markets & Data | 페이지 정보: 영문 211 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계 정형외과용 기기 시장 규모는 2023년 436억 달러로 평가되며 2031년에는 634억 3,000만 달러에 달할 것으로 예상되며, 2024-2031년 예측 기간 동안 4.8%의 CAGR을 기록할 것으로 예상됩니다. 인구 통계학적 변화, 기술 발전, 정부 이니셔티브, 신흥 시장, 정형외과 질환의 높은 위험성 등 다양한 요인이 세계 정형외과용 기기 시장에 영향을 미치고 있습니다.

인구 고령화는 골다공증 및 골관절염과 같은 정형외과 질환의 유병률 증가로 이어지는 중요한 이유이며, 이는 정형외과용 기기 수요를 주도하고 있습니다. 기술 발전은 환자의 예후를 개선하고 세계 정형외과용 기기 시장의 성장을 촉진하는 데 중요한 역할을 하고 있습니다. 이러한 발전에는 막대, 스페이서, 핀, 케이지, 플레이트, 나사 등 관절과 뼈의 근골격계 합병증을 관리하기 위해 설계된 첨단 정형외과용 기기의 개발이 포함됩니다. 또한, 정형외과용 기기 연구개발에 대한 정부의 노력과 자금 지원은 세계 정형외과용 기기 시장의 성장을 촉진하고 있으며, 신흥국 시장은 정형외과용 기기 제조업체들에게 사업 확장의 잠재력을 제공하고 있습니다.

퇴행성 골질환과 교통사고 증가 등 정형외과 질환의 위험이 높아지면서 정형외과용 기기 세계 시장 성장에 박차를 가하고 있습니다. 좌식 생활과 비만은 근골격계 질환의 조기 발병에 영향을 미치고 있으며, 이는 정형외과용 기기에 대한 수요를 더욱 증가시키고 있습니다. 시장 확대의 주요 이유는 최소침습 수술법의 가용성과 그 이점에 대한 소비자의 인식이 높아졌기 때문입니다. 새로운 치료법의 존재와 기술적으로 진보된 정형외과용 기기에 대한 환자들의 높은 지식은 세계 정형외과용 기기 시장의 급격한 성장에 기여하고 있습니다.

세계 정형외과용 기기 시장은 베이비붐 세대의 고령화와 과체중 및 비만 증가로 인해 큰 폭으로 성장하고 있습니다. 예측에 따르면, 2050년까지 60세 이상 인구가 전 세계 인구의 두 배인 21억 명에 달할 것으로 예상됩니다. 또한, 80세 이상 노인의 수는 2020-2050년 사이에 3배 증가하여 4억 2,600만 명에 이를 것으로 예상됩니다. 세계보건기구(WHO)에 따르면 전 세계 비만 인구는 10억 명을 넘어섰으며, 그 중 성인 6억 5,000만 명, 청소년 3억 4,000만 명, 소아 3,900만 명으로 집계됐습니다. 세계비만연합은 2020년 전 세계 약 7억 7,000만 명의 성인이 비만의 영향을 받는 것으로 추정하고 있으며, 대책을 마련하지 않는 한 2030년에는 이 수치가 10억 명을 넘어설 것으로 예상하고 있습니다.

이 보고서는 세계 정형외과용 기기 시장을 조사하여 시장 개요와 함께 제품별, 용도별, 부위별, 최종사용자별, 지역별 동향, 시장 진입 기업 개요 등을 제공합니다.

목차

제1장 조사 방법

제2장 프로젝트 범위와 정의

제3장 주요 요약

제4장 세계의 정형외과용 기기 시장 전망, 2017-2031년

  • 시장 규모와 예측
  • 제품별
  • 용도별
  • 부위별
  • 최종사용자별
  • 지역별
  • 기업별 시장 점유율(%), 2023년

제5장 세계의 정형외과용 기기 시장 전망, 지역별, 2017-2031년

  • 북미
  • 유럽
  • 남미
  • 아시아태평양
  • 중동 및 아프리카

제6장 시장 매핑, 2023년

제7장 거시적 환경과 산업 구조

  • 수급 분석
  • 수출입 분석
  • 밸류체인 분석
  • PESTEL 분석
  • Porter's Five Forces 분석

제8장 시장 역학

제9장 규제 프레임워크와 혁신

제10장 주요 진출 기업 상황

제11장 가격 분석

제12장 사례 연구

제13장 주요 기업 전망

  • Stryker Corporation
  • DePuy Synthes(Johnson & Johnson)
  • Medtronic plc
  • NuVasive, Inc.
  • CONMED Corporation
  • Medacta International
  • Acumed LLC
  • Enovis Corporation
  • Orthofix US LLC.
  • Aesculap, Inc.
  • Globus Medical, Inc.
  • Smith & Nephew plc

제14장 전략적 제안

제15장 문의와 면책사항

ksm 24.02.19

Global orthopedic devices market size was valued at USD 43.6 billion in 2023, which is expected to reach USD 63.43 billion in 2031, with a CAGR of 4.8% for the forecast period between 2024 and 2031F. Various factors, including changing demographics, technological advancements, government initiatives, emerging markets, and the high risk of orthopedic disorders influence the global orthopedic devices market.

The aging population is a significant reason that leads to the higher prevalence of orthopedic disorders, such as osteoporosis and osteoarthritis, driving the demand for orthopedic devices. Technological advancements play a crucial role in improving patient outcomes and driving the growth of the global orthopedic devices market. These advancements include the development of advanced orthopedic devices designed to manage musculoskeletal complications of the joints or bones, such as rods, spacers, pins, cages, plates, and screws. Additionally, government initiatives and funding for research and development of orthopedic devices are promoting the growth of the global orthopedic devices market, while emerging markets provide potential for orthopedic device manufacturers to expand their reach.

The high risk of orthopedic disorders, including degenerative bone disease and the increasing number of road accidents, is fueling the growth of the global orthopedic devices market. Sedentary routines and obesity are contributing to the early onset of musculoskeletal disorders, further propelling the demand for orthopedic devices. The market is expanding primarily due to the availability of minimally invasive surgical methods and growing consumer awareness of their advantages. The presence of new treatment alternatives and a high level of patient knowledge regarding technologically advanced orthopedic devices are contributing factors to the rapid expansion of global orthopedic devices market.

Changing Demographics

The global orthopedic devices market is experiencing significant growth due to the aging baby boomer population and the increasing number of overweight and obese individuals. Forecasts indicate that by 2050, there will be twice as many people in the globe who are 60 years of age or older-that is, 2.1 billion people. Additionally, the number of persons aged 80 or older is expected to triple between 2020 and 2050, reaching 426 million. According to the World Health Organization (WHO), the number of obese people worldwide has exceeded one billion, including 650 million adults, 340 million adolescents, and 39 million children. The World Obesity Federation estimated that in 2020, around 770 million adults globally were affected by obesity, and the figure is anticipated to exceed one billion by 2030 unless acted upon.

The rising incidence of orthopedic conditions, such as degenerative bone disease, and the growing geriatric population are driving growth in the global orthopedic devices market. The need for orthopedic devices is increasing rapidly due to the aging baby boomer population and the increase in the number of overweight and obese individuals. These factors contribute to the high demand for orthopedic devices, which is expected to grow as the global population ages and obesity rates rise.

Technological Advancements

The global orthopedic devices market is experiencing significant growth, driven by technological advancements. Innovations in materials and design have improved the durability and performance of orthopedic devices, leading to better patient outcomes. Advancements in robotics, 3D printing, and computer-aided surgeries are expected to attract numerous orthopedic surgeries, further driving the market growth. It is expected that in the upcoming years, there will be an increasing need for orthopedic devices due to the growth of orthopedic research, advancements in technology, and the acceptance of sedentary and inactive lifestyles.

Additionally, the development of bioabsorbable and titanium implants is expected to drive significant growth in the market. The market is expanding as a result of the growing use of minimally invasive surgical procedures and the introduction of new therapeutic alternatives. It is anticipated that these technological developments will keep propelling the expansion of the global orthopedic devices market, enhancing patient results, and broadening the spectrum of therapy alternatives accessible to patients. For instance, in June 2023, Dr. Lauren Geaney of UConn Health introduced an innovative approach to restore pain-free mobility using a 3D-printed custom ankle replacement, offering a solution to previously unsolvable issues.

Government Initiatives

Governments globally are implementing various measures to support the orthopedic devices industry, leading to growth in the global orthopedic devices market. The market is being driven by factors such as the prevalence of orthopedic disorders, the growing aging population, lifestyle changes, obesity, and an increase in injuries related to accidents and sports. Additionally, the availability of advanced orthopedic devices, rapid development in healthcare infrastructure, and rising awareness about minimally invasive surgical techniques positively influence market growth. Furthermore, government initiatives to support the healthcare industry and growing awareness among surgeons and patients about the latest orthopedic treatments will likely support the industry's growth.

In February 2023, the United Kingdom government granted GBP 5 million to 22 projects to drive cutting-edge treatments and technologies to support veterans' healthcare. Among these projects is a set of four initiatives led by Imperial College London, which focuses on developing prosthetics, including innovative implants to alleviate limb pain. The projects will leverage advanced surgery techniques and improve patient prosthetics, ultimately contributing to better healthcare outcomes for veterans.

Growing Demand for Foot and Ankle Treatments

The increasing demand for foot and ankle orthopedic treatments is a significant driving factor for the global orthopedic devices market. The rising prevalence of musculoskeletal and osteoporosis-related conditions, particularly among the geriatric population, is a key factor contributing to the market growth. The growing number of sports-related injuries and the increasing participation in sporting activities have significantly increased the demand for orthopedic devices in the global market.

Advancements in technology have resulted in increased adoption of minimally invasive surgeries for the orthopedic segment, leading to improved patient outcomes and expanded treatment options. The high prevalence of orthopedic disorders, increasing joint surgical procedures, and rising technological developments drive the growth of the global orthopedic devices market, offering new possibilities for personalized and effective treatments.

For instance, in October 2023, DePuy Synthes, the orthopedic device business of Johnson & Johnson, obtained FDA 510(k) clearance for its TriLeap lower extremity anatomic plating system. The system is specifically designed to address the complex needs of orthopedic surgeons, doctors of podiatric medicine, and foot and ankle specialists.

Internal Fixation Devices are Transforming the Market

Internal fixation devices play a transformative role in the global orthopedic devices market. These devices are used in internal fixation surgeries, which involve placing devices to treat broken bones and frequently employing orthopedic devices for anchoring fractured bones. The increasing demand for foot and ankle orthopedic treatments is a significant driving factor for the global orthopedic devices market. The market is expanding due to a number of factors, including the ageing population, growing incidence of sports-related injuries, growing prevalence of musculoskeletal ailments, and growing technological breakthroughs. For instance, in March 2023, NuVasive, Inc., announced that it had obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of its Precice all-internal limb lengthening solution to include pediatric patients. The expanded clearance broadens the clinical benefits of Precice to a wider range of patients.

Future Market Scenario

A major boom in the orthopedic and medical device manufacturing sector is anticipated in the upcoming years, mostly due to the ageing population and their increasing need for high-quality orthopedic and medical equipment. The burgeoning senior population, a high risk of osteoporosis and osteoarthritis, the rising incidence of joint replacement and sports injuries globally are all expected to contribute to the significant growth of the global orthopedic devices market. Orthopedic device performance and durability have increased due to technological breakthroughs and material and design innovations; this has improved patient outcomes and spurred market expansion. The rising demand for foot and ankle orthopedic treatments is a significant driving factor for the global orthopedic devices market, propelled by factors such as the increasing prevalence of osteoporosis and musculoskeletal diseases, technological advancements, and the growing incidence of sports and traumatic injuries.

Key Players Landscape and Outlook

The global orthopedic devices market is experiencing significant growth. As a result, major companies in the industry are acquiring other companies to increase their hold in the market and capitalize on the growing demand for orthopedic devices. These mergers and acquisitions allow companies to grow on their product portfolios, enter new markets, and gain access to advanced technologies, ultimately leading to increased market share and revenue. By acquiring other companies, these major players aim to stay ahead of the competition, offer innovative products, and meet the growing demand for orthopedic devices.

For instance, in May 2023, Zimmer Biomet announced the acquisition of New Zealand-based Ossis, a company specializing in personalized 3D-printed implants and complex hip replacements. The acquisition follows a successful partnership that began in Asia-Pacific in July 2021, with an agreement between Zimmer Biomet and Ossis for patient-specific 3D-printed titanium hip joint replacements and other pelvic bone replacement surgery products.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Orthopedic Devices Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. Value
    • 4.1.2. Volume
  • 4.2. By Product
    • 4.2.1. Orthopedic Prosthetics
      • 4.2.1.1. Dynamic Response Prostheses
      • 4.2.1.2. Microprocessor-controlled Prostheses
      • 4.2.1.3. Solid Ankle Cushion Heel Prostheses
      • 4.2.1.4. Single-axial Prostheses
      • 4.2.1.5. Multi-axial Prostheses
    • 4.2.2. Orthopedic Replacement Devices
      • 4.2.2.1. Shoulder Replacement Devices
      • 4.2.2.2. Elbow Replacement Devices
      • 4.2.2.3. Wrist Replacement Devices
      • 4.2.2.4. Hip Replacement Devices
      • 4.2.2.5. Ankle Replacement Devices
      • 4.2.2.6. Knee Replacement Devices
    • 4.2.3. Orthopedic Fixation Devices
      • 4.2.3.1. Internal Fixation Devices
      • 4.2.3.2. External Fixation Devices
    • 4.2.4. Spinal Implants and Surgical Devices
      • 4.2.4.1. Spinal Fusion Devices
      • 4.2.4.2. Spinal Non-fusion Devices
    • 4.2.5. Orthopedic Braces and Support Products
      • 4.2.5.1. Hand and Wrist Braces and Support Products
      • 4.2.5.2. Facial Braces and Support Products
      • 4.2.5.3. Ankle Braces and Support Products
      • 4.2.5.4. Knee Braces and Support
      • 4.2.5.5. Foot Walkers and Orthoses
      • 4.2.5.6. Shoulder Braces and Support Products
      • 4.2.5.7. Elbow Braces and Support Products
      • 4.2.5.8. Back, Hip and Spine Braces and Support Products
    • 4.2.6. Arthroscopy Instruments
    • 4.2.7. Orthobiologics
    • 4.2.8. Bone Graft Substitutes
  • 4.3. By Application
    • 4.3.1. Diabetic Foot Diseases
    • 4.3.2. Ligament Injuries
    • 4.3.3. Fracture Treatment Recovery
    • 4.3.4. Spinal Fusion, Fixation and Decompression
    • 4.3.5. Neurological Disorders
    • 4.3.6. Rheumatoid Arthritis and Osteoarthritis
  • 4.4. By Site
    • 4.4.1. Spine
    • 4.4.2. Arm and Elbow
    • 4.4.3. Foot and Ankle
    • 4.4.4. Hip and Pelvis
    • 4.4.5. Knee and Thigh
    • 4.4.6. Shoulder
    • 4.4.7. Craniomaxillofacial
    • 4.4.8. Hand and Wrist
  • 4.5. By End-users
    • 4.5.1. Hospitals and Surgical Centers
    • 4.5.2. Orthopedic Clinics
    • 4.5.3. Ambulatory and Trauma Care Centers
    • 4.5.4. Home Care Settings
    • 4.5.5. Others
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. South America
    • 4.6.4. Asia-Pacific
    • 4.6.5. Middle East and Africa
  • 4.7. By Company Market Share (%), 2023

5. Global Orthopedic Devices Market Outlook, By Region, 2017-2031F

  • 5.1 North America*
    • 5.1.1 Market Size & Forecast
      • 5.1.1.1 Value
      • 5.1.1.2 Volume
    • 5.1.2 By Product
      • 5.1.2.1 Orthopedic Prosthetics
      • 5.1.2.1.1 Dynamic Response Prostheses
      • 5.1.2.1.2 Microprocessor-controlled Prostheses
      • 5.1.2.1.3 Solid Ankle Cushion Heel Prostheses
      • 5.1.2.1.4 Single-axial Prostheses
      • 5.1.2.1.5 Multi-axial Prostheses
      • 5.1.2.2 Orthopedic Replacement Devices
      • 5.1.2.2.1 Shoulder Replacement Devices
      • 5.1.2.2.2 Elbow Replacement Devices
      • 5.1.2.2.3 Wrist Replacement Devices
      • 5.1.2.2.4 Hip Replacement Devices
      • 5.1.2.2.5 Ankle Replacement Devices
      • 5.1.2.2.6 Knee Replacement Devices
      • 5.1.2.3 Orthopedic Fixation Devices
      • 5.1.2.3.1 Internal Fixation Devices
      • 5.1.2.3.2 External Fixation Devices
      • 5.1.2.4 Spinal Implants and Surgical Devices
      • 5.1.2.4.1 Spinal Fusion Devices
      • 5.1.2.4.2 Spinal Non-fusion Devices
      • 5.1.2.5 Orthopedic Braces and Support Products
      • 5.1.2.5.1 Hand and Wrist Braces and Support Products
      • 5.1.2.5.2 Facial Braces and Support Products
      • 5.1.2.5.3 Ankle Braces and Support Products
      • 5.1.2.5.4 Knee Braces and Support
      • 5.1.2.5.5 Foot Walkers and Orthoses
      • 5.1.2.5.6 Shoulder Braces and Support Products
      • 5.1.2.5.7 Elbow Braces and Support Products
      • 5.1.2.5.8 Back, Hip and Spine Braces and Support Products
      • 5.1.2.6 Arthroscopy Instruments
      • 5.1.2.7 Orthobiologics
      • 5.1.2.8 Bone Graft Substitutes
    • 5.1.3 By Application
      • 5.1.3.1 Diabetic Foot Diseases
      • 5.1.3.2 Ligament Injuries
      • 5.1.3.3 Fracture Treatment Recovery
      • 5.1.3.4 Spinal Fusion, Fixation and Decompression
      • 5.1.3.5 Neurological Disorders
      • 5.1.3.6 Rheumatoid Arthritis and Osteoarthritis
    • 5.1.4 By Site
      • 5.1.4.1 Spine
      • 5.1.4.2 Arm and Elbow
      • 5.1.4.3 Foot and Ankle
      • 5.1.4.4 Hip and Pelvis
      • 5.1.4.5 Knee and Thigh
      • 5.1.4.6 Shoulder
      • 5.1.4.7 Craniomaxillofacial
      • 5.1.4.8 Hand and Wrist
    • 5.1.5 By End-users
      • 5.1.5.1 Hospitals and Surgical Centers
      • 5.1.5.2 Orthopedic Clinics
      • 5.1.5.3 Ambulatory and Trauma Care Centers
      • 5.1.5.4 Home Care Settings
      • 5.1.5.5 Others
    • 5.1.6 United States*
      • 5.1.6.1 Market Size & Forecast
      • 5.1.6.1.1 Value
      • 5.1.6.1.2 Volume
      • 5.1.6.2 By Product
      • 5.1.6.2.1 Orthopedic Prosthetics
      • 5.1.6.2.1.1 Dynamic Response Prostheses
      • 5.1.6.2.1.2 Microprocessor-controlled Prostheses
      • 5.1.6.2.1.3 Solid Ankle Cushion Heel Prostheses
      • 5.1.6.2.1.4 Single-axial Prostheses
      • 5.1.6.2.1.5 Multi-axial Prostheses
      • 5.1.6.2.2 Orthopedic Replacement Devices
      • 5.1.6.2.2.1 Shoulder Replacement Devices
      • 5.1.6.2.2.2 Elbow Replacement Devices
      • 5.1.6.2.2.3 Wrist Replacement Devices
      • 5.1.6.2.2.4 Hip Replacement Devices
      • 5.1.6.2.2.5 Ankle Replacement Devices
      • 5.1.6.2.2.6 Knee Replacement Devices
      • 5.1.6.2.3 Orthopedic Fixation Devices
      • 5.1.6.2.3.1 Internal Fixation Devices
      • 5.1.6.2.3.2 External Fixation Devices
      • 5.1.6.2.4 Spinal Implants and Surgical Devices
      • 5.1.6.2.4.1 Spinal Fusion Devices
      • 5.1.6.2.4.2 Spinal Non-fusion Devices
      • 5.1.6.2.5 Orthopedic Braces and Support Products
      • 5.1.6.2.5.1 Hand and Wrist Braces and Support Products
      • 5.1.6.2.5.2 Facial Braces and Support Products
      • 5.1.6.2.5.3 Ankle Braces and Support Products
      • 5.1.6.2.5.4 Knee Braces and Support
      • 5.1.6.2.5.5 Foot Walkers and Orthoses
      • 5.1.6.2.5.6 Shoulder Braces and Support Products
      • 5.1.6.2.5.7 Elbow Braces and Support Products
      • 5.1.6.2.5.8 Back, Hip and Spine Braces and Support Products
      • 5.1.6.2.6 Arthroscopy Instruments
      • 5.1.6.2.7 Orthobiologics
      • 5.1.6.2.8 Bone Graft Substitutes
      • 5.1.6.3 By Application
      • 5.1.6.3.1 Diabetic Foot Diseases
      • 5.1.6.3.2 Ligament Injuries
      • 5.1.6.3.3 Fracture Treatment Recovery
      • 5.1.6.3.4 Spinal Fusion, Fixation and Decompression
      • 5.1.6.3.5 Neurological Disorders
      • 5.1.6.3.6 Rheumatoid Arthritis and Osteoarthritis
      • 5.1.6.4 By Site
      • 5.1.6.4.1 Spine
      • 5.1.6.4.2 Arm and Elbow
      • 5.1.6.4.3 Foot and Ankle
      • 5.1.6.4.4 Hip and Pelvis
      • 5.1.6.4.5 Knee and Thigh
      • 5.1.6.4.6 Shoulder
      • 5.1.6.4.7 Craniomaxillofacial
      • 5.1.6.4.8 Hand and Wrist
      • 5.1.6.5 By End-users
      • 5.1.6.5.1 Hospitals and Surgical Centers
      • 5.1.6.5.2 Orthopedic Clinics
      • 5.1.6.5.3 Ambulatory and Trauma Care Centers
      • 5.1.6.5.4 Home Care Settings
      • 5.1.6.5.5 Others
    • 5.1.7 Canada
    • 5.1.8 Mexico

All segments will be provided for all regions and countries covered:

  • 5.2 Europe
    • 5.2.1 Germany
    • 5.2.2 France
    • 5.2.3 Italy
    • 5.2.4 United Kingdom
    • 5.2.5 Russia
    • 5.2.6 Netherlands
    • 5.2.7 Spain
    • 5.2.8 Turkey
    • 5.2.9 Poland
  • 5.3 South America
    • 5.3.1 Brazil
    • 5.3.2 Argentina
  • 5.4 Asia-Pacific
    • 5.4.1 India
    • 5.4.2 China
    • 5.4.3 Japan
    • 5.4.4 Australia
    • 5.4.5 Vietnam
    • 5.4.6 South Korea
    • 5.4.7 Indonesia
    • 5.4.8 Philippines
  • 5.5 Middle East & Africa
    • 5.5.1 Saudi Arabia
    • 5.5.2 UAE
    • 5.5.3 South Africa

6. Market Mapping, 2023

  • 6.1. By Product
  • 6.2. By Application
  • 6.3. By Site
  • 6.4. By End-users
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 10.1 Clinical Trials
  • 10.2 Patent Landscape
  • 10.3 Regulatory Approvals
  • 10.4 Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Stryker Corporation
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. DePuy Synthes (Johnson & Johnson)
  • 13.3. Medtronic plc
  • 13.4. NuVasive, Inc.
  • 13.5. CONMED Corporation
  • 13.6. Medacta International
  • 13.7. Acumed LLC
  • 13.8. Enovis Corporation
  • 13.9. Orthofix US LLC.
  • 13.10. Aesculap, Inc.
  • 13.11. Globus Medical, Inc.
  • 13.12. Smith & Nephew plc

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제